Butyrate: A potential mediator of obesity and microbiome via different mechanisms of actions
Meryem Saban Güler, Sabriye Arslan, Duygu Ağagündüz, Ida Cerqua, Ester Pagano, Roberto Berni Canani, Raffaele Capasso
Abstract
• Butyrate is primarily produced by gut bacteria fermenting dietary fibers. • Butyrate acts as an inhibitor of HDAC and through GPCR-mediated signaling pathways. • The efficacy of obesity is still being studied due to a lack of human trials. • It may improve intestinal health, energy metabolism, and obesity challenges. • Its gut-brain axis and microbiome effects show its function in host physiology. Butyrate, a short-chain fatty acid, is a crucial product of gut microbial fermentation with significant implications for various metabolic and physiological processes. Dietary sources of butyrate are limited, primarily derived from the fermentation of dietary fibers by butyrate-producing gut bacteria. Butyrate exerts its effects primarily as a histone deacetylase (HDAC) inhibitor and through signaling pathways involving G protein-coupled receptors (GPCRs). Its diverse benefits include promoting gut health, enhancing energy metabolism, and potentially alleviating complications associated with obesity. However, the exact role of butyrate in obesity is still under investigation, with a limited number of human trials necessitating further research to determine its efficacy and safety profile. Moreover, butyrate impact on the gut-brain axis and its modulation of microbiome effect on behavior highlight its broader importance in regulating host physiology. A thorough understanding of the metabolic pathways and mechanisms of butyrate is essential for developing targeted interventions for metabolic disorders. Continued research is crucial to fully realize its therapeutic potential and optimize its clinical applications in human health. In summary, this review illuminates the multifaceted role of butyrate as a potential mediator of obesity and related metabolic changes.